Clinical
Perspectives from Avrielle Peltz, OT – Rehabologym (
Drawing directly from her clinical experience, Peltz emphasizes that “it isn’t cancer patients—it’s cancer survivors” who form the core of this rehabilitation need. This distinction is powerful. It recognizes that survival introduces a new phase of care—one where the body and brain must be retrained, supported, and stabilized in order to restore independence and quality of life.
The
Hidden Burden: Treatment-Induced Dysfunction
Peltz confirms what many survivors report but few systems fully address: nearly every cancer treatment carries downstream consequences. Cognitive dysfunction—commonly referred to as “chemo brain”—is among the most prevalent. Patients experience memory loss, brain fog, reduced attention span, and impaired executive functioning. These are not abstract neurological issues; they translate into real dangers, such as forgetting to turn off a stove, missing medications, or struggling with basic organization and safety at home.
Beyond cognition, Peltz highlights more severe neurological complications, including radiation necrosis, where treatment damages healthy brain tissue. This can lead to visual disturbances, balance deficits, sensory hypersensitivity, and auditory disruptions. The variability of these symptoms underscores a key insight: rehabilitation must be individualized, because the side effects are driven not just by cancer type, but by the biological impact of treatment itself.
When
Treatment Limits Survival
One of the most striking points
from Peltz’s interview is the paradox many patients face: the very treatments
designed to save their lives can weaken them to the point where they can no
longer tolerate continued therapy. Severe deconditioning, immune suppression,
and systemic fatigue may force patients to stop chemotherapy or radiation
prematurely.
This insight leads to a critical recommendation—prehabilitation. Peltz strongly advocates for initiating rehabilitation at the time of diagnosis, not after treatment. By establishing baseline measurements across cognitive, physical, and functional systems, clinicians can track decline, intervene early, and maintain resilience throughout the cancer journey. This proactive approach allows patients not only to endure treatment, but to function during and after it.
A
Whole-Body, Systems-Based Approach
At Rehabologym, cancer rehabilitation is not limited to a single domain—it is a full-body systems evaluation and intervention model. Peltz outlines a comprehensive framework that includes:
- Cognitive retraining: Addressing memory, attention, and executive dysfunction through functional task-based therapy
- Motor and balance rehabilitation: Improving coordination, gait, and fall prevention
- Sensory and perceptual retraining: Managing neuropathy, altered sensation, and spatial awareness deficits
- Visual and reaction-time training: Especially critical for safety and independence
- Sleep and circadian regulation: Structuring daily rhythms to support recovery
- Swelling and lymphatic management: Addressing edema and fluid imbalances
- Endurance and respiratory training: Targeting fatigue and oxygen efficiency
Real-Life
Function: Therapy That Translates
Peltz consistently returns to one central principle: therapy must translate into real life. Her interventions are not confined to the clinic—they are designed to restore meaningful participation in daily activities.
For example, she describes working with a pediatric brain cancer survivor who could not walk a single block without exhaustion. Through targeted breathing strategies and pacing techniques, the goal was not simply to improve endurance, but to enable him to play with friends without feeling different.
In another case, a high-profile adult patient resisted using a walker due to public visibility. Peltz developed a creative workaround—using a dog stroller as a functional mobility aid—allowing the patient to maintain independence while preserving dignity and privacy.
These examples illustrate a defining strength of occupational therapy: it adapts rehabilitation to the patient’s life, not the other way around.
Restoring
Independence :
Driving & Cognitive Integration
One of the most advanced aspects of Rehabologym’s program is its driver rehabilitation system. For cancer survivors with neurological impairments, driving becomes a major safety concern. Peltz’s team uses simulation-based testing to evaluate reaction time, cognition, motor coordination, and visual processing.
Patients must meet objective benchmarks—such as performing repeated brake-to-accelerator transitions within strict time limits—to ensure safety. If deficits are identified, adaptive technologies (e.g., hand controls, left-foot accelerators) are introduced and tested before real-world application.
This process does more than restore mobility—it protects patients legally and functionally, ensuring they can maintain independence without compromising safety.
Objective
Measurement: From Subjective Care to Quantifiable Outcomes
A cornerstone of Peltz’s philosophy is the use of objective, measurable data. She challenges traditional subjective assessments, emphasizing that human variability can skew results. Instead, Rehabologym integrates kinematic measurements and technology-driven metrics to track progress with precision—mirroring approaches used in advanced research settings.
Her background in research and collaboration with institutions such as
A
New Model for Cancer Care
Peltz’s insights point toward a necessary evolution in oncology: the integration of rehabilitation as a standard, continuous component of care. Her model advocates for:
- Early intervention (prehabilitation)
- Continuous monitoring throughout treatment
- Multisystem rehabilitation strategies
- Objective measurement and validation
- Personalized, goal-driven care
This approach aligns seamlessly with emerging survivorship models and initiatives like RehabScan™, where the goal is not simply to treat disease, but to restore the human experience of living.
Conclusion:
Redefining What It Means to Heal
Avrielle Peltz’s work challenges the conventional endpoint of cancer care. Survival is not the finish line—it is the beginning of a new journey. Through occupational therapy, that journey becomes navigable.
Her message is clear: cancer survivors are not defined by what they’ve endured, but by what they can regain. With the right rehabilitation strategies—rooted in science, personalization, and real-world function—patients can move beyond survival toward true recovery, independence, and quality of life.





.jpg)

.jpg)
















